Case Study: Merck & Co. achieves stronger phishing protection and email governance with Fortra Agari DMARC Protection

Merck & Co. Chooses Agari DMARC Protection

Merck & Co., a Global 500 pharmaceutical company, needed to protect employees, domains, and products from phishing, domain spoofing, executive impersonation, and unauthorized email senders. The company selected Fortra’s Agari DMARC Protection to improve email security and control third-party marketing vendors while addressing targeted inbound email attacks.

Fortra implemented Agari DMARC Protection to manage DMARC, SPF, and DKIM authentication, provide sender discovery and governance, and monitor brand abuse. The results included stronger email governance and compliance, better protection for acquired domains, and detection of new third-party senders; Merck & Co. also reported rejecting 80,000 emails through DMARC policy and a dramatic reduction in phishing attacks.

Merck & Co.